Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
DW12LD
|
|||
Drug Name |
NO-13065
|
|||
Indication | Obesity [ICD-11: 5B81; ICD-10: E66] | Phase 1 | [1] | |
Company |
Otsuka Pharmaceutical
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT04838639) A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Effect of NO-13065 When Administered Orally to Healthy and Obese Adult Subjects. U.S.National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.